Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RUltragenyx Pharmaceutical Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

Ultragenyx Pharmaceutical Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $214M. Net result −$92M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $214M. Running result $214M. Product: $112M. Royalty: $102M.
  • Cost of revenue: −$34M. Running result $180M.
  • Gross profit: $180M. Running result $180M.
  • Operating costs: −$255M. Running result −$75M.
  • Operating income: −$75M. Running result −$75M.
  • Other expense: −$16M. Running result −$91M.
  • Pre-tax loss: −$91M. Running result −$91M.
  • Income tax expense: −$1M. Running result −$92M.
  • Net loss: −$92M. Running result −$92M.